Incruse Ellipta TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: umeclidinium
Brand name
(ARTG)
: INCRUSE ELLIPTA umeclidinium (as bromide) 62.5 microgram powder for inhalationDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Incruse Ellipta is indicated as a long term once daily maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD)
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Inhalation, powder for
- Inhalation
- A plastic inhaler with a light grey body and a light green mouthpiece cover containing one strip of blister containing a white powder.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- See Product information for shelf life
- Shelf lifetime is 24 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 30 pack
- 7 (sample pack) pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient umeclidinium
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
